Dr. Reddy's Laboratories Limited
RDY
$13.03
-$0.23-1.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 794.72M | 979.63M | 1.01B | 998.56M | 982.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 794.72M | 979.63M | 1.01B | 998.56M | 982.71M |
| Cost of Revenue | 438.49M | 454.21M | 457.15M | 430.32M | 436.67M |
| Gross Profit | 356.23M | 525.42M | 551.41M | 568.24M | 546.03M |
| SG&A Expenses | 293.54M | 302.17M | 302.81M | 299.70M | 277.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -7.33M | -6.63M | -8.48M | -9.10M | -16.15M |
| Total Operating Expenses | 782.47M | 818.77M | 822.52M | 793.89M | 782.28M |
| Operating Income | 12.25M | 160.86M | 186.04M | 204.67M | 200.42M |
| Income Before Tax | 21.05M | 173.20M | 210.19M | 222.58M | 231.69M |
| Income Tax Expenses | -2.26M | 39.66M | 46.74M | 57.86M | 48.32M |
| Earnings from Continuing Operations | 23.31M | 133.54M | 163.44M | 164.72M | 183.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -42.30K | 2.27M | 1.19M | 958.20K | 762.50K |
| Net Income | 23.27M | 135.81M | 164.63M | 165.68M | 184.13M |
| EBIT | 12.25M | 160.86M | 186.04M | 204.67M | 200.42M |
| EBITDA | 53.22M | 219.38M | 243.90M | 260.36M | 238.61M |
| EPS Basic | 0.03 | 0.16 | 0.20 | 0.20 | 0.22 |
| Normalized Basic EPS | 0.01 | 0.13 | 0.15 | 0.16 | 0.17 |
| EPS Diluted | 0.03 | 0.16 | 0.20 | 0.20 | 0.22 |
| Normalized Diluted EPS | 0.01 | 0.13 | 0.15 | 0.16 | 0.17 |
| Average Basic Shares Outstanding | 833.71M | 832.62M | 832.68M | 832.04M | 833.19M |
| Average Diluted Shares Outstanding | 833.71M | 833.20M | 833.16M | 833.02M | 834.07M |
| Dividend Per Share | 0.08 | -- | -- | -- | 0.09 |
| Payout Ratio | 0.00% | 0.00% | 46.33% | -- | 0.00% |